Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Willmes CG"'
Autor:
Willmes CG; Editor, Trends in Molecular Medicine. Electronic address: cwillmes@cell.com.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2022 May; Vol. 28 (5), pp. 345-346. Date of Electronic Publication: 2022 Apr 08.
Autor:
Willmes CG; Editor, Trends in Molecular Medicine. Electronic address: tmm@cell.com.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2021 Dec; Vol. 27 (12), pp. 1085-1087. Date of Electronic Publication: 2021 Oct 11.
Autor:
Willmes CG; Editor, Trends in Molecular Medicine. Electronic address: tmm@cell.com., Beymer M; Editor, Trends in Endocrinology and Metabolism. Electronic address: mbeymer@cell.com.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2021 Aug; Vol. 27 (8), pp. 713-714. Date of Electronic Publication: 2021 Jun 28.
Autor:
Beymer M; Editor, Trends in Endocrinology and Metabolism. Electronic address: tem@cell.com., Willmes CG; Editor, Trends in Molecular Medicine. Electronic address: cwillmes@cell.com.
Publikováno v:
Trends in endocrinology and metabolism: TEM [Trends Endocrinol Metab] 2021 Aug; Vol. 32 (8), pp. 531-532. Date of Electronic Publication: 2021 Jun 28.
Autor:
Willmes CG; Editor, Trends in Molecular Medicine. Electronic address: tmm@cell.com.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2021 Jan; Vol. 27 (1), pp. 1. Date of Electronic Publication: 2020 Dec 08.
Autor:
Willmes CG; Editor, Trends in Molecular Medicine. Electronic address: tmm@cell.com.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2020 Sep; Vol. 26 (9), pp. 797-798.
Autor:
Brockmann MM; Institut für Neurophysiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Maglione M; Freie Universität Berlin, Institut für Biologie, Berlin, Germany.; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.; NeuroCure Cluster of Excellence, Berlin, Germany., Willmes CG; DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany., Stumpf A; Neuroscience Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Bouazza BA; Institut für Neurophysiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Velasquez LM; Neuroscience Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Grauel MK; Institut für Neurophysiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Beed P; Neuroscience Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Lehmann M; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany., Gimber N; Neuroscience Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schmoranzer J; NeuroCure Cluster of Excellence, Berlin, Germany., Sigrist SJ; Freie Universität Berlin, Institut für Biologie, Berlin, Germany.; NeuroCure Cluster of Excellence, Berlin, Germany.; DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany., Rosenmund C; Institut für Neurophysiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Cluster of Excellence, Berlin, Germany., Schmitz D; NeuroCure Cluster of Excellence, Berlin, Germany.; DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany.; Neuroscience Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Publikováno v:
ELife [Elife] 2019 Sep 19; Vol. 8. Date of Electronic Publication: 2019 Sep 19.
Autor:
Willmes CG; Institute of Biochemistry, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; NeuroCure - Cluster of Excellence, Charité - Universitätsmedizin Berlin, Germany., Mack TG; Institute of Biochemistry, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Ledderose J; Institute of Biochemistry, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany., Schmitz D; NeuroCure - Cluster of Excellence, Charité - Universitätsmedizin Berlin, Germany.; Neuroscience Research Center (NWFZ), Charité Universitätsmedizin, 10117 Berlin, Germany., Wozny C; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK., Eickholt BJ; Institute of Biochemistry, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.; NeuroCure - Cluster of Excellence, Charité - Universitätsmedizin Berlin, Germany.
Publikováno v:
Scientific reports [Sci Rep] 2017 Feb 15; Vol. 7, pp. 42652. Date of Electronic Publication: 2017 Feb 15.
Autor:
Grauel MK; Institute of Neurophysiology, Charité Universitätsmedizin, 10117 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Institute of Biology, Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany., Maglione M; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Institute of Biology, Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany; Department of Molecular Pharmacology and Cell Biology, Leibniz Institut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany., Reddy-Alla S; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Institute of Biology, Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany., Willmes CG; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Institute of Biochemistry, Charité Universitätsmedizin, 10117 Berlin, Germany; Neuroscience Research Center (NWFZ), Charité Universitätsmedizin, 10117 Berlin, Germany., Brockmann MM; Institute of Neurophysiology, Charité Universitätsmedizin, 10117 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany., Trimbuch T; Institute of Neurophysiology, Charité Universitätsmedizin, 10117 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany., Rosenmund T; Institute of Neurophysiology, Charité Universitätsmedizin, 10117 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany., Pangalos M; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Neuroscience Research Center (NWFZ), Charité Universitätsmedizin, 10117 Berlin, Germany., Vardar G; Institute of Neurophysiology, Charité Universitätsmedizin, 10117 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany., Stumpf A; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Neuroscience Research Center (NWFZ), Charité Universitätsmedizin, 10117 Berlin, Germany., Walter AM; Molecular and Theoretical Neuroscience, Leibniz-Institut für Molekulare Pharmakologie, 10117 Berlin, Germany., Rost BR; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Neuroscience Research Center (NWFZ), Charité Universitätsmedizin, 10117 Berlin, Germany; DZNE- German Center for Neurodegenerative Diseases, Charité Universitätsmedizin, 10117 Berlin, Germany., Eickholt BJ; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Institute of Biochemistry, Charité Universitätsmedizin, 10117 Berlin, Germany., Haucke V; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Department of Molecular Pharmacology and Cell Biology, Leibniz Institut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany; Institute of Chemistry and Biochemistry, Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany., Schmitz D; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Neuroscience Research Center (NWFZ), Charité Universitätsmedizin, 10117 Berlin, Germany; DZNE- German Center for Neurodegenerative Diseases, Charité Universitätsmedizin, 10117 Berlin, Germany; christian.rosenmund@charite.de dietmar.schmitz@charite.de stephan.sigrist@fu-berlin.de., Sigrist SJ; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; Institute of Biology, Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany; christian.rosenmund@charite.de dietmar.schmitz@charite.de stephan.sigrist@fu-berlin.de., Rosenmund C; Institute of Neurophysiology, Charité Universitätsmedizin, 10117 Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, 10117 Berlin, Germany; christian.rosenmund@charite.de dietmar.schmitz@charite.de stephan.sigrist@fu-berlin.de.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2016 Oct 11; Vol. 113 (41), pp. 11615-11620. Date of Electronic Publication: 2016 Sep 26.